These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 25841277)

  • 1. PET/MR in dementia and other neurodegenerative diseases.
    Barthel H; Schroeter ML; Hoffmann KT; Sabri O
    Semin Nucl Med; 2015 May; 45(3):224-33. PubMed ID: 25841277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid PET-MRI Applications in Movement Disorders.
    Tondo G; Esposito M; Dervenoulas G; Wilson H; Politis M; Pagano G
    Int Rev Neurobiol; 2019; 144():211-257. PubMed ID: 30638455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical PET/MR Imaging in Dementia and Neuro-Oncology.
    Henriksen OM; Marner L; Law I
    PET Clin; 2016 Oct; 11(4):441-52. PubMed ID: 27593248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone.
    Andersen FL; Ladefoged CN; Beyer T; Keller SH; Hansen AE; Højgaard L; Kjær A; Law I; Holm S
    Neuroimage; 2014 Jan; 84():206-16. PubMed ID: 23994317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.
    Del Sole A; Malaspina S; Magenta Biasina A
    Funct Neurol; 2016; 31(4):205-215. PubMed ID: 28072381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for ¹⁸F-FDG Brain Imaging in Patients Examined for Suspected Dementia.
    Hitz S; Habekost C; Fürst S; Delso G; Förster S; Ziegler S; Nekolla SG; Souvatzoglou M; Beer AJ; Grimmer T; Eiber M; Schwaiger M; Drzezga A
    J Nucl Med; 2014 Jun; 55(6):923-31. PubMed ID: 24833495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular hybrid imaging using PET/MRI.
    Nensa F; Schlosser T
    Rofo; 2014 Dec; 186(12):1094-101. PubMed ID: 25184216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/MR in Breast Cancer.
    Tabouret-Viaud C; Botsikas D; Delattre BM; Mainta I; Amzalag G; Rager O; Vinh-Hung V; Miralbell R; Ratib O
    Semin Nucl Med; 2015 Jul; 45(4):304-21. PubMed ID: 26050658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging clinical issues and multivariate analyses in PET investigations.
    Arbizu J; Giuliani A; Gállego Perez-Larraya J; Riverol M; Jonsson C; García-García B; Morales M; Imaz L; Pagani M
    Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):386-404. PubMed ID: 28750498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging.
    Silverman DH
    J Nucl Med; 2004 Apr; 45(4):594-607. PubMed ID: 15073255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG PET/MR Imaging in Major Neurocognitive Disorders.
    Mainta IC; Perani D; Delattre BM; Assal F; Haller S; Vargas MI; Zekry DS; Frisoni GB; Zaidi H; Ratib O; Garibotto V
    Curr Alzheimer Res; 2017; 14(2):186-197. PubMed ID: 27334943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/MRI of central nervous system: current status and future perspective.
    Yang ZL; Zhang LJ
    Eur Radiol; 2016 Oct; 26(10):3534-41. PubMed ID: 26780640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Role of PET/MR Imaging in Dementia?
    Dupont P
    Semin Nucl Med; 2021 May; 51(3):296-302. PubMed ID: 33526230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR-based attenuation correction using ultrashort-echo-time pulse sequences in dementia patients.
    Cabello J; Lukas M; Förster S; Pyka T; Nekolla SG; Ziegler SI
    J Nucl Med; 2015 Mar; 56(3):423-9. PubMed ID: 25678486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Arterial Spin-Labeling MR Imaging to Screen for Typical and Atypical Neurodegenerative Disease in the New Era of Alzheimer Treatment.
    Lee K; Mahmud M; Marx D; Yasen W; Sharma O; Ivanidze J; Zan E; Zhou L; Li Y; de Leon MJ; Nordvig AS; Chiang GC
    AJNR Am J Neuroradiol; 2024 May; 45(5):632-636. PubMed ID: 38485200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Positron Emission Tomography-Magnetic Resonance Imaging: Current Status and Future Directions.
    Lau JMC; Raptis DA; Laforest R; Nensa F; Zheng J; Gropler RJ; Woodard PK
    J Thorac Imaging; 2018 May; 33(3):139-146. PubMed ID: 29489584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid PET/MR imaging: physics and technical considerations.
    Shah SN; Huang SS
    Abdom Imaging; 2015 Aug; 40(6):1358-65. PubMed ID: 25985965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR/PET: a new challenge in hybrid imaging.
    Werner MK; Schmidt H; Schwenzer NF
    AJR Am J Roentgenol; 2012 Aug; 199(2):272-7. PubMed ID: 22826387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging in Dementias.
    Mahalingam S; Chen MK
    Semin Neurol; 2019 Apr; 39(2):188-199. PubMed ID: 30925612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.